Vaccine Watch: 5 dead in Serum Institute fire; UAE okays Sputnik
PM likely to be vaccinated in March or April, doctor in Shivamogga dies two days after receiving jab and Israel denies vaccine efficacy fears
The Pfizer vaccine may not be the best choice for frail people, but it’s too early to make firm conclusions
While the deaths of elderly people in Norway are sad, they shouldn’t be cause for alarm. This actually tells us the vaccine is stimulating …
Update COVID-19 vaccine to target omicron variants: Advisory panel to USFDA
Unclear which combination of updated vaccine will work best; body expected to decide by July
New Delta+ variant found in India can escape antibodies
Mutations in the Delta+ variant can render vaccines and treatments ineffective
Making COVID-19 vaccines in Africa: Advances and sustainability issues
Demand, market for locally produced vaccines critical for sustainability of 15 COVID-19 vaccines manufacturing facilities
COVID-19 surge: Why has China not attained herd immunity despite high vaccination coverage?
Germany, South Korea, Vietnam are also reporting increase in COVID-19 cases despite extensive vaccination
COVID-19 vaccines are coming – how will we know they work and are safe?
The results of the Pfizer vaccine trial are highly promising. But the road to eradicating the coronavirus is likely to be long and difficult
COVID vaccines: How to make sense of reports on their effectiveness
Real-world trials come with some problems: The target of vaccination, what time it was rolled out and emerging variants
Delaying the second COVID-19 vaccine dose: A medical expert answers key questions
The uncertainty is around how long the protective effect of the first dose will last without a second shot
Lateral Thoughts: Waiting for the vaccine?
Vaccination programmes cannot be dealt with outside the purview of public health
Why other African countries need to guard against South Africa COVID-19 variant
WHO and African Centres for Disease Control to strengthen genomic surveillance capacities
Dummy’s guide to how trade rules affect access to COVID-19 vaccines
The WTO is considering whether to temporarily waive certain rules about TRIPS, to allow more countries access to vaccines, drugs needed to …
COVID-19 vaccines: How Pfizer and Moderna’s 95% effective mRNA shots work
Should we expect the pandemic to be over once a vaccine is available for public use? Not exactly. A vaccine will not be perfect, and it takes …
Moderna’s COVID vaccine reports 95% efficacy. It means we might have multiple successful vaccines
It opens the door to the possibility we might have many successful vaccines, and be able to tailor different vaccines to people with different needs
WATCH: Will mixing COVID-19 vaccines be effective?
Some early studies have shown that combining vaccines produce a better immune response. But the efficacy of the vaccine combination is yet to be …
Effectiveness of COVID-19 vaccines against infection, severe disease declined with new variants; here's how
AstraZeneca vaccine provided least protection against infection, showed most rapid decline
COVID-19: Pfizer, AstraZeneca efficacy significantly reduced against omicron, says UK health agency
Omicron is displaying growth advantage over delta and is poised to become dominant variant in UK
Covaxin effective against UK Strain: What does this mean in absence of efficacy data?
Being a whole-virus vaccine doesn’t give Bharat Biotech product any advantage at this stage, say experts
Lateral Thoughts: Waiting for bad news
Adverse reactions are part and parcel of vaccination. We can know about safety of COVID-19 vaccines being used in India only after people receive …
COVID-19 immunity: how long does it last?
In UK’s second wave, previously infected health workers were either completely protected from reinfection or were asymptomatic
Pfizer withdraws application for Emergency Use Authorisation in India
The company will resubmit application after getting more data
Omicron may already be in most countries, WHO warns
People dismissing omicron infection as mild may fuel spread, says WHO
COVID-19 vaccine: Oxford-AstraZeneca up to 90% effective in late stage trial
Adenovirus vaccine can be stored at 2-8°C; company to apply for emergency authorisation
Experts suggest updating vaccines for new variants. How does it work & what are the challenges?
It is easier to update certain vaccine platforms than others, say experts
COVID-19 Challenge 2021: How does the world overcome vaccine shortage
The pharmaceuticals industry must come together to ensure all adults are vaccinated against the novel coronavirus; …